Troutman Pepper represented Pyramid Laboratories, Inc., a leading drug product contract development and manufacturing organization (CDMO), in securing a growth investment from Audax Private Equity, a leading alternative investment manager and capital partner. Read a company press release about the investment.
Founded in 1988, Pyramid provides formulation development, analytical and stability testing, as well as aseptic fill-finish manufacturing services focused on large molecule therapeutics. The company has built a strong reputation for quality, technical expertise, and dedication to customer service with a comprehensive offering spanning preclinical development to scaled commercial manufacturing and distribution services.
The team advising Pyramid was led by Todd Boylan and Chris Miller (health sciences) and included Samantha Peruto, Daisy Flores, and Jenny Ji (corporate); Morgan Klinzing (tax); and Judy O’Grady (regulatory).